MedCity News November 15, 2021
While much progress has been made, many patients have molecular drivers of disease that are not detected, interpreted and acted upon with precision therapies, leaving potential life-changing treatments on the table.
Precision medicine is a powerful tool in the treatment of cancer and rare diseases, with broad potential to transform patient outcomes. While much progress has been made, many patients have molecular drivers of disease that are not detected, interpreted and acted upon with precision therapies, leaving potential life-changing treatments on the table.
Despite a growing body of scientific evidence, a number of roadblocks stand in the way of implementing precision medicine approaches in practice. Broad collaboration between industry and key stakeholders – patient organizations, multi-disciplinary healthcare teams, laboratories and...
Today's Sponsors
Today's Sponsor